Re: Reply from Sarah

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reply from Sarah

in response to

Reply from Sarah

BearDownAZ

posted on Dec 11, 2015 02:31PM

"It doesn't exactly provide much clarity to the issues of 34.4M shares, $34.4M dollars, $1 per share, or the individual valuation of the RPSs or Technology Assets."

My understanding of it has improved 0.00%. Thanks for the attempt.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply